Candidates typically include patients with recurrent or difficult-to-treat gliomas, meningiomas, or select metastases—especially after prior radiation.

Eligibility depends on tumor pathology, location, prior therapies, and surgical goals.

We explain benefits, risks, and how GammaTile fits into your overall plan. Learn more at Atlantic Brain and Spine.